z-logo
Premium
Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: A prospective, controlled trial compared with endoscopic injection sclerotherapy
Author(s) -
Gotoh Yudai,
Iwakiri Ryuichi,
Sakata Yasushi,
Koyama Takanori,
Noda Takahiro,
Matsunaga Chika,
Ogata ShinIchi,
Ishibashi Sadatoshi,
Sakata Hiroyuki,
Tsunada Seiji,
Fujimoto Kazuma
Publication year - 1999
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1046/j.1440-1746.1999.01841.x
Subject(s) - medicine , sclerotherapy , varices , cirrhosis , varix , surgery , ligation , randomized controlled trial , endoscopy , portal hypertension , prospective cohort study , esophageal varices , gastroenterology
Background : To evaluate the efficacy of endoscopic variceal ligation (EVL) in prophylactic therapy for oesophageal varices, we performed a randomized prospective trial to compare the recurrence of oesophageal varices treated by EVL with those treated by endoscopic injection sclerotherapy. Methods : Fifty patients with liver cirrhosis were divided into two groups at random, after informed consents were obtained, to receive prophylactic therapy for bleeding of oesophageal varices. Group 1 patients underwent sessions of sclerotherapy with 5% ethanolamine oleate used as the sclerosant. Group 2 patients underwent EVL followed by one or two sessions of sclerotherapy. Results : During the 18 month follow‐up period, both the recurrence rate in group 2 (56%) and the incidence of bleeding (20%) were significantly higher compared with group 1 (recurrence rate 16%, bleeding 0%). Conclusions : This result indicates that EVL is not effective for prophylactic therapy for oesophageal varices in liver cirrhosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here